Politics and Policy

Some experts argue that prescription drug monitoring programs can be a game changer when it comes to curbing prescription abuse and misuse. Here are 11 states that stand out for their PDMPs (or lack thereof).

A recent Supreme Court decision shines the spotlight on the healthcare price transparency debate.

As patients look to make more informed decisions about healthcare services, payers can leverage comparative analytics to deliver greater price transparency

Here are three questions payers must ask to determine providers’ readiness to engage in risk-based reimbursement.

State and federal regulations, health information breaches, create a minefield of issues

Concerns among stakeholders may call for EHR system revamping

An in-depth look at the effects of PDMPs, which are electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.

While value-based reimbursement presents opportunities for payers and providers, succeeding in such a reimbursement model can be challenging. Here are four things to strive for that could increase the likelihood of success in a value-based reimbursement model.

In the move to value-based care, there have been surprises and disruptions for payers and providers alike. In this Q&A, an expert shares where we are now.

Here’s a closer look at what the presidential candidates vow to do if elected to the Oval Office.

The court will consider whether an “accommodation” allowing nonprofit religiously-affiliated organizations to opt out of the ACA requirement that insurance plans include contraception coverage is consistent with the Religious Freedom Restoration Act (RFRA).

An Affordable Care Act payment model is showing that chronically ill patients can be better taken care of in their own homes while bringing down the long-term cost of care.

During the keynote session at the Advanced Payment Models in Healthcare Conference 2016, PwC experts shared how MACRA legislation will affect reimbursement.

New Health Care Cost Institute analysis examines the value that can be derived from providing cost and quality information for non-emergency healthcare services.

We asked industry insiders to detail and analyze each component of Trump’s healthcare plan.

Agency hits 30% value-based target goal 11 months ahead of schedule.

Surprising way a group of surveyed physicians are saying what they think is the best way to control costs.

Health insurance plans will soon receive ratings based on how many doctors and hospitals they include in their networks.

Cost issues work their way into medical school curricula

A quick progress report on efforts to improve price transparency in the United States, as well as some state-by-state information.

Before it hits you, take time to consider effective benefit strategies

CMS and AHIP, together with physician groups and other stakeholders, announce alignment and simplification of quality measures.

N.Y. Gov. Andrew Cuomo proposes a budget provision that would call for capping prices on some drugs and requiring drug companies to provide information about their costs.

The precision medicine uptake is not as fast as predicted in healthcare organizations, but academic medical centers are jumping on board faster than others.

The Commonwealth Fund examined the effects of the ACA’s Medicaid expansion on low income adults in three states that took different approaches to the law. Here’s what they found.